TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33388991

Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Turbinate outfracture in combination with radiofrequency ablation
Number of subjects: 58
Study: 36332826

Group type: EXPERIMENTAL
Intervention: PelviSense-assisted PFMT
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: CB-assisted PFMT
Number of subjects: 51

Group type: COMPARATOR
Intervention: PFMT alone
Number of subjects: 51
Study: 32446245

Group type: EXPERIMENTAL
Intervention: Psilocybin (0.17 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35949295

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 308

Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 308
Study: 33127858

Group type: EXPERIMENTAL
Intervention: Measured waist-to-hip ratio increase of 0.06
Number of subjects: 281228

Group type: EXPERIMENTAL
Intervention: Measured BMI increase of 5-kg/m2
Number of subjects: 281228

Group type: EXPERIMENTAL
Intervention: Genetically-predicted waist-to-hip ratio increase of 0.06
Number of subjects: 281228

Group type: EXPERIMENTAL
Intervention: Genetically-predicted BMI increase of 5-kg/m2
Number of subjects: 281228

Group type: COMPARATOR
Intervention: Adjustment for diabetes and measured BP
Number of subjects: 281228

Group type: COMPARATOR
Intervention: Mediator adjustment using multivariable MR for genetically-predicted waist-to-hip ratio
Number of subjects: 281228

Group type: COMPARATOR
Intervention: Mediator adjustment using multivariable MR for genetically-predicted BMI
Number of subjects: 281228
Study: 32314026

Group type: EXPERIMENTAL
Intervention: CNN segmentation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adjusted segmentations
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CNN segmentations
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CNN model
Number of subjects: 40
Study: 33000985

Group type: EXPERIMENTAL
Intervention: Brief anti-ageism messages addressing views of aging
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control group (no message)
Number of subjects: 349
Study: 32727703

Group type: EXPERIMENTAL
Intervention: Tongue-to-palate resistance training (TPRT) for 8 weeks (5 days per week)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual daily activities (Control group)
Number of subjects: 91
Study: 34656996

Group type: EXPERIMENTAL
Intervention: Automatically titrating O2-system (ATOS) targeting SpO2 of 92%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Automatically titrating O2-system (ATOS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Exercise titrated constant flow oxygen system (CFOS)
Number of subjects: 50
Study: 33566351

Group type: EXPERIMENTAL
Intervention: Video instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Face-to-face instructions
Number of subjects: 0
Study: 32701929

Group type: EXPERIMENTAL
Intervention: Leukocyte‐ and platelet‐rich fibrin (L‐PRF) used to fill and cover extraction sockets (n=11, Test Group)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No L‐PRF used (n=12, Control Group)
Number of subjects: 23
Study: 36127447

Group type: EXPERIMENTAL
Intervention: Sensory level electrical stimulation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Motor level electrical stimulation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combined groups (Sensory and Motor)
Number of subjects: 31
Study: 35590052

Group type: EXPERIMENTAL
Intervention: Draughts Comic Strip
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soap Opera Comic Strip
Number of subjects: 0
Study: 36046939

Group type: EXPERIMENTAL
Intervention: In-person lifestyle intervention (LI)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Telephone conference call lifestyle intervention (LI)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Medical nutrition therapy (MNT)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LI) arms
Number of subjects: 211
Study: 33510421

Group type: EXPERIMENTAL
Intervention: Early antenatal counseling of prematurity
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard counseling by MFM providers
Number of subjects: 76
Study: 34914682

Group type: EXPERIMENTAL
Intervention: SMART educational intervention (four learning modules on goal setting and coaching)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: SMART educational intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 68
Study: 33059008

Group type: EXPERIMENTAL
Intervention: 5% Nannochloropsis oculata
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 10% Nannochloropsis oculata
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 15% Nannochloropsis oculata
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (0% Nannochloropsis oculata)
Number of subjects: 4
Study: 35708992

Group type: EXPERIMENTAL
Intervention: Solution‐Focused Group Psychoeducation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 32946618

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 1004
Study: 33728707

Group type: EXPERIMENTAL
Intervention: Bulk fill composite resin (BF)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Stainless steel crowns (SSC)
Number of subjects: 91
Study: 34443998

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) application
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no PRF application)
Number of subjects: 90
Study: 32665432

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 171
Study: 36472969

Group type: EXPERIMENTAL
Intervention: ZingiVir-H
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 34228172

Group type: EXPERIMENTAL
Intervention: Self-reported symptoms after treatment
Number of subjects: 579
Study: 32278781

Group type: EXPERIMENTAL
Intervention: 50 mg of immediate-release venlafaxine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34460029

Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 22
Study: 34138909

Group type: EXPERIMENTAL
Intervention: COVID-19 convalescent plasma (CCP) collection and processing
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Testing for transfusion transmissible infections (TTIs)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Antibody titer testing
Number of subjects: 192
Study: 36029336

Group type: EXPERIMENTAL
Intervention: Accuro (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional method (group C)
Number of subjects: 60
Study: 33026175

Group type: EXPERIMENTAL
Intervention: 160 IU intranasal insulin (IN-INS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 30
Study: 36092515

Group type: EXPERIMENTAL
Intervention: Gum Arabic (GA) powder, applied twice a day for 60 days.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microcrystalline cellulose powder (placebo), applied twice a day for 60 days.
Number of subjects: 60
Study: 32725809

Group type: EXPERIMENTAL
Intervention: Repeated lifestyle counselling (IG)
Number of subjects: 1783

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 1783
Study: 35691288

Group type: EXPERIMENTAL
Intervention: Individual LiFE intervention (n = 156)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Group-based LiFE intervention (n = 153)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Both LiFE formats (Individual and Group-based)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Both formats (Individual and Group-based)
Number of subjects: 309
Study: 33891798

Group type: EXPERIMENTAL
Intervention: Transanal reinforcement (TAR)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Protective ileostomy (PI)
Number of subjects: 54
Study: 32438420

Group type: COMPARATOR
Intervention: Sham interventions (e.g., saline injections into spinal structures, peripheral nerves, cranial surgery, spine surgery)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Double blinded RCTs
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Single blinded RCTs
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Unreported blinding
Number of subjects: 82
Study: 36171147

Group type: EXPERIMENTAL
Intervention: Messages about specific harms and chemicals of VLNCs
Number of subjects: 1763

Group type: EXPERIMENTAL
Intervention: Messages with information about quitting efficacy
Number of subjects: 1763
Study: 33811747

Group type: EXPERIMENTAL
Intervention: High energy diet (3,450 kcal/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Medium energy diet (3,150 kcal/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low energy diet (2,850 kcal/kg)
Number of subjects: 45
Study: 36314990

Group type: EXPERIMENTAL
Intervention: HIIT: 4x4 minutes at 95% maximal aerobic speed (MAS) with 3 minutes active breaks
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SIT: 8x20 seconds at 150% MAS with 10 seconds passive breaks
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SIT: 10x30 seconds at 175% MAS with 3.5 minutes active breaks
Number of subjects: 48
Study: 32205769

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic treatment (ABT) per PEG protocol (n=78)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Any ABT (per PEG protocol or clinical indication) (n=115)
Number of subjects: 297
Study: 35288018

Group type: EXPERIMENTAL
Intervention: Active PSI-rTMS
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham PSI-rTMS
Number of subjects: 31
Study: 32706674

Group type: EXPERIMENTAL
Intervention: Self-directed web-based education and exercise therapy for 6 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led education and exercise therapy (face-to-face or telerehabilitation) for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Face-to-face physiotherapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Telerehabilitation physiotherapy
Number of subjects: 35
Study: 33782552

Group type: EXPERIMENTAL
Intervention: Genetic risk APOL1 variants intervention for hypertension management
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic testing for medications managing acute and chronic pain and depression
Number of subjects: 2
Study: 36028916

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy with arthroplasty (ACDA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anterior cervical discectomy with fusion (ACDF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACDA
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 0
Study: 33509394

Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (minor: ≥3 and <5 g/dl) without overt bleeding
Number of subjects: 7781

Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (major: ≥5 g/dl) without overt bleeding
Number of subjects: 7781

Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (minor: ≥3 and <5 g/dl) with overt bleeding
Number of subjects: 7781

Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (major: ≥5 g/dl) with overt bleeding
Number of subjects: 7781
Study: 33112644

Group type: EXPERIMENTAL
Intervention: ΔΔP (change in driving pressure) after ventilator adjustments
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: ΔPaO2/FIO2 (change in oxygenation) after ventilator adjustments
Number of subjects: 968
Study: 35577476

Group type: EXPERIMENTAL
Intervention: Systemic lidocaine (1.5 mg/kg bolus, followed by 1.5 mg/kg/hour infusion until the end of surgery)
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Placebo (0.9% saline, identical volumes and rates)
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Systemic lidocaine
Number of subjects: 1020
Study: 33615769

Group type: EXPERIMENTAL
Intervention: Electric toothbrush/irrigator combination (test)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual toothbrush alone (control)
Number of subjects: 60
Study: 34353864

Group type: EXPERIMENTAL
Intervention: Inulin 20g
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Inulin 20g + Psyllium 20g
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Psyllium 20g
Number of subjects: 19

Group type: COMPARATOR
Intervention: Dextrose 20g (placebo)
Number of subjects: 19
Study: 33470941

Group type: EXPERIMENTAL
Intervention: Habits Heart App (intervention group)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (paper education material)
Number of subjects: 28
Study: 32807241

Group type: EXPERIMENTAL
Intervention: LMWH + steroid group
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: UFH + steroid group
Number of subjects: 210

Group type: COMPARATOR
Intervention: LMWH group
Number of subjects: 210
Study: 35257687

Group type: EXPERIMENTAL
Intervention: Particulate matter with aerodynamic diameter ≤10 μm (PM10)
Number of subjects: 1425

Group type: EXPERIMENTAL
Intervention: Particulate matter with aerodynamic diameter ≤2.5 μm (PM2.5)
Number of subjects: 1425

Group type: EXPERIMENTAL
Intervention: Black carbon (BC)
Number of subjects: 1425

Group type: EXPERIMENTAL
Intervention: Change in carotid intima-media thickness (cIMT)
Number of subjects: 1425
Study: 34204694

Group type: EXPERIMENTAL
Intervention: Modified Tap Dance Program (MTD)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 44
Study: 35731547

Group type: EXPERIMENTAL
Intervention: Fully engaged parents
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Partially engaged parents
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Independently engaged parents
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Fully engaged children
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Partially engaged children
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Dabblers
Number of subjects: 214
Study: 35213594

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 33285695

Group type: EXPERIMENTAL
Intervention: OxyContin with standardized nursing care
Number of subjects: 90

Group type: COMPARATOR
Intervention: OxyContin
Number of subjects: 90
Study: 36102440

Group type: EXPERIMENTAL
Intervention: Face-to-face aerobic exercise
Number of subjects: 25

Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 25
Study: 33499889

Group type: EXPERIMENTAL
Intervention: Cough severity in women
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Cough severity in men
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: CQLQ total score for women
Number of subjects: 180

Group type: COMPARATOR
Intervention: CQLQ total score for men
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gender modification effect
Number of subjects: 180
Study: 36206400

Group type: EXPERIMENTAL
Intervention: Belimumab (1, 4, or 10 mg/kg intravenous or 200 mg subcutaneous) plus standard therapy
Number of subjects: 4170

Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 4170

Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 4170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4170
Study: 32131611

Group type: EXPERIMENTAL
Intervention: 81 mg low-dose aspirin (COX-1 inhibitor) for 2 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 45
Study: 35807781

Group type: EXPERIMENTAL
Intervention: Farm-to-School Nutrition and Gardening Intervention
Number of subjects: 193

Group type: COMPARATOR
Intervention: Wait-list Control
Number of subjects: 193
Study: 33822767

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 113450

Group type: EXPERIMENTAL
Intervention: Terazosin/alfuzosin/doxazosin
Number of subjects: 113450

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 113450
Study: 34041705

Group type: EXPERIMENTAL
Intervention: Caregiver depressive symptoms (measured by Center for Epidemiologic Studies Depression scale)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Moderate asthma at baseline
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Severe asthma at baseline
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Household income < $20,000 per year
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Fall season
Number of subjects: 208
Study: 32762319

Group type: EXPERIMENTAL
Intervention: DSM-IV PTSD Checklist
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: DSM-5 PTSD Checklist
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Blended version of PTSD Checklist
Number of subjects: 128
Study: 33492500

Group type: EXPERIMENTAL
Intervention: Oral hydrocortisone sodium succinate and aluminum phosphate gel (OHA)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Endoscopic loco-regional triamcinolone acetonide injection (ETI) plus oral prednisone
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: OHA
Number of subjects: 63

Group type: COMPARATOR
Intervention: ETI plus oral prednisone
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Mucosal defect > 11/12 circumference
Number of subjects: 63
Study: 34455688

Group type: EXPERIMENTAL
Intervention: Prehospital antiplatelet therapy
Number of subjects: 17347

Group type: COMPARATOR
Intervention: Non-antiplatelet therapy
Number of subjects: 17347
Study: 35791089

Group type: EXPERIMENTAL
Intervention: Infuza
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Kulzam
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Infuza & Kulzam
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 251
Study: 32372486

Group type: EXPERIMENTAL
Intervention: Nitrate treatment (various preparations and doses)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Nitrate treatment (pooled active treatment groups)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 35840446

Group type: EXPERIMENTAL
Intervention: Densah burs
Number of subjects: 12

Group type: COMPARATOR
Intervention: Osteotome
Number of subjects: 12
Study: 34735046

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1500

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1500
Study: 32621630

Group type: EXPERIMENTAL
Intervention: Couple-based meditation (CBM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Supportive-expressive (SE)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 75
Study: 35860190

Group type: EXPERIMENTAL
Intervention: Shenling Chengqi decoction combined with routine treatment for 7 days
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 160
Study: 33840150

Group type: EXPERIMENTAL
Intervention: EW nebuliser
Number of subjects: 15

Group type: COMPARATOR
Intervention: DV 646 nebuliser
Number of subjects: 15
Study: 32053417

Group type: EXPERIMENTAL
Intervention: Lower-body positive pressure (LBPP) treadmill running with 60% body weight
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower-body positive pressure (LBPP) treadmill running with 100% body weight
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lower-body positive pressure (LBPP) treadmill running
Number of subjects: 20
Study: 36123103

Group type: EXPERIMENTAL
Intervention: Nudge design of electronic point-of-care randomisation prompt with liberal magnesium supplementation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nudge design of electronic point-of-care randomisation prompt with restrictive magnesium supplementation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Preference design of electronic point-of-care randomisation prompt with liberal magnesium supplementation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Preference design of electronic point-of-care randomisation prompt with restrictive magnesium supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nudge and Preference designs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pre-emptive and opt-out consent models
Number of subjects: 50
Study: 33105277

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia of 20% sevoflurane emulsion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Inhalation anesthesia of sevoflurane
Number of subjects: 6
Study: 35960908

Group type: EXPERIMENTAL
Intervention: Elotuzumab combined with pomalidomide/dexamethasone (EPd)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Pomalidomide/dexamethasone (Pd)
Number of subjects: 117
Study: 33580663

Group type: EXPERIMENTAL
Intervention: Heart Failure Exercise and Resistance Training (HEART) Camp
Number of subjects: 204
Study: 32516301

Group type: EXPERIMENTAL
Intervention: TPAD training with visual feedback and task-specific overground training
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: TPAD training
Number of subjects: 11
Study: 33870873

Group type: EXPERIMENTAL
Intervention: Ergonomics training intervention
Number of subjects: 0
Study: 33207094

Group type: EXPERIMENTAL
Intervention: Lorlatinib
Number of subjects: 296

Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 296
Study: 35112178

Group type: COMPARATOR
Intervention: Local periarticular infiltration anaesthesia (LIA) with 60 ml of ropivacaine 0.5% and 1 ml of dexmedetomidine (100 µg ml‐1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided regional anaesthesia (USRA) with two single-shot femoral and popliteal blocks, each with 15 ml of ropivacaine 0.5% and 0.5 ml of dexmedetomidine
Number of subjects: 50
Study: 33910879

Group type: EXPERIMENTAL
Intervention: Korean Red ginseng
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no ginseng)
Number of subjects: 26
Study: 33784802

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV dexamethasone 5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 32682696

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: eCDSS
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: eCDSS-PLUS
Number of subjects: 524
Study: 35439347

Group type: EXPERIMENTAL
Intervention: Rezafungin 10 mg single subcutaneous dose
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rezafungin (various doses: 1, 10, 30, 60, 100, or 200 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50